Radar de Ensayos Clínicos | Bavarian Nordic

Avanzado

IA Trial Radar Candidato a Ensayo Clínico o Paciente Cuidador de Pacientes Profesional de la Salud Profesional de Biotecnología Inversor en Biotecnología Investigador Otro
	Discutamos y exploremos los ensayos clínicos con Bavarian Nordic como patrocinador principal o colaborador. Puedo ayudarle a entender sus condiciones de salud, tratamientos o encontrar ensayos clínicos cercanos.

Nuestra herramienta de búsqueda solo admite inglés. Para búsquedas y discusiones en otros idiomas, use la IA Trial Radar o seleccione los filtros de condición médica y ubicación a continuación.

Buscar por sitio, centro...

Buscar por palabras clave...

Título del estudio	Estado
An Efficacy, Safety, and Immunogenicity Study of CHIKV VLP Vaccine for the Prevention of Chikungunya Disease in Adolescents and Adults NCT07467707	Aún no recluta
Comparability Trial of the MVA-BN Vaccine Manufactured in Different Production Cells NCT07199569	Reclutando
A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children. NCT07003984	Reclutando
A Phase 2 Trial in Healthy Adult Participants of the Recombinant MVA-BN-WEV Vaccine NCT06899802	Activo, no reclutando
Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC (PregInPoxVac) NCT06844500	Activo, no reclutando
Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC (PregInPoxVac) NCT06844487	Reclutando
Long-term Follow-up Study to Evaluate Safety and Immunogenicity of PXVX0317 Single or Booster Vaccination NCT06007183	Activo, no reclutando
Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years NCT05349617	CompletadoResultados publicados
ABNCoV2 Vaccine in Adult Subjects Previously Vaccinated for SARS-CoV-2 NCT05329220	CompletadoResultados publicados
MVA-BN-RSV Vaccine Trial NCT05238025	TerminadoResultados publicados
ABNCoV2 Vaccine in SARS-CoV-2 (COVID-19) Seronegative and Seropositive Adult Subjects NCT05077267	CompletadoResultados publicados
A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine) NCT05072080	CompletadoResultados publicados
A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus Virus-Like Particle Vaccine (CHIKV VLP) NCT05065983	CompletadoResultados publicados
Phase 2a Study of MVA-BN-RSV Vaccination and RSV Challenge in Healthy Adults NCT04752644	Completado
TAEK-VAC-HerBy Vaccine for Brachyury and HER2 Expressing Cancer NCT04246671	Completado
A Phase 1 Open Label Trial of Intravenous Administration of MVA-BN-Brachyury Vaccine in Patients With Advanced Cancer NCT04134312	Completado
Vaccination Trial of a Recombinant MVA-BN-WEV Vaccine in Healthy Adult Subjects NCT04131595	Completado
Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317) (WRAIR) NCT03992872	CompletadoResultados publicados
Freeze-Dried MVA-BN® Lot Consistency Smallpox Trial NCT03699124	CompletadoResultados publicados
CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer NCT03628716	CompletadoResultados publicados
Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix NCT03610581	TerminadoResultados publicados
BN Brachyury and Radiation in Chordoma NCT03595228	CompletadoResultados publicados
A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC NCT03547999	TerminadoResultados publicados
Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer NCT03532217	Completado
Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults NCT03483961	CompletadoResultados publicados
Special Access Program IMVAMUNE® NCT03472014	CompletadoResultados publicados
Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma NCT03376659	TerminadoResultados publicados
Safety and Tolerability Trial (MVA-BN-Brachyury/FPV-Brachyury) NCT03349983	Completado
VAXCHORA Pediatric Study to Assess Safety and Immunogenicity NCT03220737	CompletadoResultados publicados
JYNNEOS Smallpox Vaccine in Adult Healthcare Personnel at Risk for Mpox in the Democratic Republic of the Congo NCT02977715	Activo, no reclutando
RSV-MVA-BN Vaccine Phase II Trial in ≥ 55 Year Old Adults NCT02873286	CompletadoResultados publicados
RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults. NCT02864628	Retirado
A Trial of CV301 in Combination With Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer NCT02840994	Completado
Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical Prostatectomy NCT02772562	TerminadoResultados publicados
Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo NCT02661464	TerminadoResultados publicados
Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancer NCT02506114	TerminadoResultados publicados
Trial to Evaluate the Safety, Tolerability and Immunogenicity of the Recombinant MVA BN® RSV Vaccine NCT02419391	Completado
Phase 4 Study To Assess The Safety Of Vivotif At Different Release Titers Among Travelers NCT02391909	Completado
A Study of Live Oral Cholera Vaccine, PXVX200 in Healthy Older Adults NCT02100631	CompletadoResultados publicados
A Phase 3 Lot to Lot Consistency Study of Live Oral Cholera Vaccine, PXVX0200 in Healthy Adults NCT02094586	CompletadoResultados publicados
Randomized, Open-label Phase II Trial to Assess the Safety and Immunogenicity of MVA-BN Smallpox Vaccine in Immunocompromised Subjects With HIV Infection NCT02038881	CompletadoResultados publicados
A Non-inferiority Trial to Compare MVA-BN® Smallpox Vaccine to ACAM2000® NCT01913353	CompletadoResultados publicados
Safety and Efficacy Challenge Study of Live Oral Cholera Vaccine Candidate,PXVX0200, to Prevent Cholera NCT01895855	CompletadoResultados publicados
A Phase II Trial to Compare a Liquid-frozen and a Freeze-dried Formulation of IMVAMUNE (MVA-BN®) Smallpox Vaccine in Vaccinia-naïve Healthy Subjects NCT01668537	CompletadoResultados publicados
Safety and Immunogenicity of the Live Oral Cholera Vaccine Candidate PXVX0200 NCT01585181	Completado
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer (Prospect) NCT01322490	CompletadoResultados publicados
A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Breast Cancer After Adjuvant Therapy NCT01152398	Completado

Fase

Tipo

Tipo de estudio

Grupo de edad

Sexo biológico

Placebo

Fase

Tipo

Tipo de estudio

Grupo de edad

Sexo biológico